Screener
Disc Medicine IRON Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total other income (expense), net | 6,071 | 5,980 |
| Loss before income taxes | (63,453) | (33,966) |
| Income tax expense | (51) | (119) |
| Net loss | $(63,504) | $(34,085) |
| Net loss per share, basic and diluted | $(1.65) | $(1.02) |
| Weighted-average common shares outstanding, basic and diluted | 38,491,433 | 33,324,745 |
| Comprehensive loss: | ||
| Net loss | $(63,504) | $(34,085) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's net income?
- Disc Medicine (IRON) reported net income of -$63.5M in Q1 2026.
- How has Disc Medicine's net income changed year-over-year?
- Disc Medicine's net income decreased by 86.3% year-over-year, from -$34.09M to -$63.5M.
- What is the long-term trend for Disc Medicine's net income?
- Over 3 years (2022 to 2025), Disc Medicine's net income has grown at a 65.5% compound annual growth rate (CAGR), from -$46.83M to -$212.18M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Disc Medicine's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude